Bensheng Wu

Bensheng Wu

Auto-generated profile, based on publicly available information

Bensheng Wu

Department of Colorectal Surgery, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 November 2019 in Gastroenterology Research and Practice
Verified
Journal Article
Open access
PDF file
QZQing Zhou
Qing Zhou
ZSZhao-Feng Shen
Zhao-Feng Shen
BWBen-Sheng Wu
Ben-Sheng Wu
CXCheng-Biao Xu
Cheng-Biao Xu
ZHZhong-Qi He
Zhong-Qi He
SHShu-Tang Han
Shu-Tang Han
Background. Ulcerative colitis (UC) patients have an increased risk for the development of colorectal cancer (CRC). Our aim was to assess the risk of CRC in UC patients compared with disease extent, disease duration, and geographic variation. Methods. In this systematic review and meta-analysis, we searched PubMed, scientific meetings, and the bibliographies of identified articles, with English language restrictions for studies published from 1988 to 2018, and assessed the risk of CRC in UC patients. Patients with Crohn’s disease, family history of CRC, and colorectal adenomatous polyp (CAP) were excluded from this research. The study was registered with PROSPERO, number CRD42018102213. Findings. We included 58 studies that included 267566 UC patients. Extensive UC and left-sided UC had a higher risk of CRC than proctitis UC. Geography also played a role in UC-associated CRC development. The time of malignant transformation in Asian UC patients started after 10-20 years of this disease duration. North American UC-associated CRC patients significantly increased in more than 30 years of this disease duration. Conclusion. In a systematic review of the literature, we found that disease extent, disease duration, and geography were strong, independent risk factors in UC-associated CRC development.

1 January 2017 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
SYShuai Yan
Shuai Yan
YYYinzi Yue
Yinzi Yue
XWXiaopeng Wang
Xiaopeng Wang
HDHong-Li Dong
Hong-Li Dong
SZShu-Guang Zhen
Shu-Guang Zhen
HQHaihua Qian
Haihua Qian
Traditional Chinese medicine was reported to have good effects in treating functional constipation. This work attempted to prove the effects of aqueous extracts of Herba Cistanche (AEHC) on STC treatment and to determine the possible mechanisms by a loperamide‐induced slow transit constipation (STC) model. HPLC was performed for identification and confirmation of the bioactive components in the AEHC. It was found that AEHC attenuated STC responses based on increased fecal quantity, moisture content, and intestinal transit rate, as well as serum levels of GAS, MTL, SS, and CGRP. The protein and mRNA levels of c‐kit, a labeling of interstitial cells of Cajal (ICC), also increased. Meanwhile, only the protein level of SCF, a ligand of c‐kit, increased. The analysis of our data suggested that AEHC could obviously improve the function of ICC via a signaling pathway involving PI3K, SCF, and c‐kit and enhance colonic motility indices such as GAS, MTL, SS, and CGRP. It is interesting to note that AEHC appeared to be effective on constipation, so further experiments are necessary to clarify the exact mechanisms involved.

30 January 2020 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
QZQing Zhou
Qing Zhou
WZWei-Xin Zhang
Wei-Xin Zhang
ZHZong-Qi He
Zong-Qi He
BWBen-Sheng Wu
Ben-Sheng Wu
ZSZhao-Feng Shen
Zhao-Feng Shen
SHShu-Tang Han
Shu-Tang Han
Background. Dehydrocostus lactone (DL), one of the main active constituents in Aucklandia lappa Decne. (Muxiang), reported to have anti‐inflammatory, antiulcer, and immunomodulatory properties. However, the effect of DL on ulcerative colitis (UC) has not been reported. To analyze the anti‐inflammatory potential role of DL in UC, we provide a mechanism for the pharmacological action of DL. Methods. The experimental model of UC was induced by using oral administration of 2% dextran sulfate sodium (DSS) with drinking water in BALB/c mice. Mesalazine (Mes, 0.52 g/kg/d), DL‐high doses (DL‐H, 20 mg/kg/d), DL‐middle doses (DL‐M, 15 mg/kg/d), DL‐low doses (DL‐L, 10 mg/kg/d) were gavaged once a day from day 4 to day 17. Disease activity index (DAI) was calculated daily. On day 18, mice were rapidly dissected and the colorectal tissues were used to detect the levels of UC‐related inflammatory cytokines (TNF‐α, IL‐1β, MCP‐1, MPO, SOD, IL‐6, IL‐17, and IL‐23), IL‐6/STAT3 inflammatory signaling pathway (iNOS, COX2, IL‐6, GP130, L‐17, and IL‐23), and colorectal mucosal barrier‐related regulatory factors (MUC2, XBP1s, and α‐defensins) by ELISA or qRT‐PCR. Results. DL reduced the colorectal inflammation histological assessment, decreased UC‐related inflammatory cytokines (TNF‐α, IL‐1β, MCP‐1, MPO, SOD, IL‐6, IL‐17, and IL‐23), downregulated IL‐6/STAT3 inflammatory signaling pathway (iNOS, COX2, IL‐6, GP130, L‐17, and IL‐23), repaired the key colorectal mucosal barrier protein‐MUC2, and inhibited the downstream pathway (XBP1s and α‐defensin). Conclusions. DL possessed the potential of anti‐inflammatory effect to treated colitis. The protective mechanism of DL may involve in reducing inflammation and improving colorectal barrier function via downregulating the IL‐6/STAT3 signaling.

10 April 2019 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
ZHZongqi He
Zongqi He
QZQing Zhou
Qing Zhou
KWKe Wen
Ke Wen
BWBensheng Wu
Bensheng Wu
XSXueliang Sun
Xueliang Sun
YCYugen Chen
Yugen Chen
Background.The nuclear factor kappa beta (NF-κB) signaling pathway plays an important role in ulcerative colitis (UC). Huangkui Lianchang decoction (HLD) is an effective traditional Chinese medicinal compound used in the treatment of UC. HLD has good effects in the clinic, but the mechanism by which HLD acts is unclear. This study aims to reveal the exact molecular mechanism of HLD in the treatment of UC.Methods. Mouse ulcerative colitis was induced by dextran sulfate sodium (DSS) and treated with HLD. Intestinal damage was assessed by disease activity index (DAI), colon macroscopic lesion scores, and histological scores. Interleukin (IL)-6, tumor necrosis factor (TNF)-α, and IL-1βwere detected in colon tissue using ELISA. Myeloperoxidase (MPO) and superoxide dismutase (SOD) activities in the colonic mucosa were measured. The levels of IL-6, inducible nitric oxide synthase (iNOS), and cyclooxygenase-2 (COX-2) in the colon were determined by real-time quantitative polymerase chain reaction (qPCR). The expression of NF-κB, IκBα, and p-IκBαin the colon was measured by Western blot.Results. After treatment with HLD, the DAI scores, macroscopic lesion scores, and histological scores decreased, and the levels of inflammatory cytokines related to the NF-κB signaling pathway, such as IL-6, TNF-α, and IL-1β, as well as those of iNOS and COX-2, were reduced; at the same time, colonic pathological damage was alleviated, and the MPO and SOD activities decreased. Western blot confirmed that HLD can inhibit the NF-κB signaling pathway in DSS-induced ulcerative colitis.Conclusion. HLD can alleviate the inflammation caused by ulcerative colitis. In particular, high doses of HLD can significantly alleviate intestinal inflammation and have comparable efficacy to Mesalazine. We propose that the anti-inflammatory activity of HLD on DSS-induced colitis in mice may involve the inhibition of the NF-κB pathway.

11 November 2023 in Phytomedicine
Verified
Journal Article
Closed access
QZQing Zhou
Qing Zhou
ZHZongqi He
Zongqi He
SYShuai Yan
Shuai Yan
XWXiaopeng Wang
Xiaopeng Wang
BWBensheng Wu
Bensheng Wu

6 May 2020 in BMC Surgery
Verified
Journal Article
Open access
PDF file
ZHZongqi He
Zongqi He
JDJun Du
Jun Du
KWKaiwen Wu
Kaiwen Wu
JCJiajia Chen
Jiajia Chen
BWBensheng Wu
Bensheng Wu
XWXiaopeng Wang
Xiaopeng Wang
Background: The choice of surgery for perianal sepsis is currently controversial. Some people advocate one-time radical surgery for perianal sepsis, while others advocate incision and drainage. The objective of this study is to observe the formation probability of secondary anal fistula after incision and drainage in patients with perianal sepsis and determine factors that contribute to secondary anal fistula after incision and drainage. Methods: A retrospective descriptive analysis was conducted in 288 patients with perianal sepsis who were treated with anorectal surgery in the Suzhou Hospital of Traditional Chinese Medicine from January 2016 to June 2018. The patients were followed by telephone, physical examination, and pelvic MRI examination for at least 1 year after surgery. Results: Three patients were not followed, 98 patients did not receive surgical treatment or one-time radical surgery for perianal sepsis, and 187 patients were ultimately identified for the study. Anal fistula was present in 105 patients, and the rate of formation of secondary anal fistula was 56.15%. There was no statistically significant difference in the fistula formation rate between different types of sepsis (P>0.05). And, in patients with secondary anal fistula, there was no significant correlation between the location of sepsis and the type of secondary anal fistula (P>0.05). Conclusions: The incidence of secondary anal fistula after incision and drainage of perianal sepsis is 56.15%, which is lower than the incidence found in previous study. Young is a risk factor for secondary anal fistula after incision and drainage of perianal sepsis. There is no significant correlation between the location of sepsis and the type of secondary anal fistula. Simple incision and drainage is a suitable choice for patients with acute perianal sepsis.